American Association for the Advancement of Science, Science Translational Medicine, 494(11), 2019
DOI: 10.1126/scitranslmed.aau6246
Full text: Unavailable
Selective inhibition of γ-secretase complexes targets T-ALL without the dose-limiting side effects of complete γ-secretase inhibition.